Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 991 AL 1005

Now and future: Strategies for diagnosis, prevention and therapies for Alzheimer's disease

Shi J, Touchon J, Middleton LT, Rovira MB, Vassar R, Vellas B, Shen Y.

Sci Bull (Beijing). 2024 Dec 15;69(23):3777-3784. doi: 10.1016/j.scib.2024.09.042. Epub 2024 Sep 28.

HIV-Associated Neurocognitive Disorder (HAND) and Alzheimer's Disease Pathogenesis: Future Directions for Diagnosis and Treatment

Mustafa M, Musselman D, Jayaweera D, da Fonseca Ferreira A, Marzouka G, Dong C.

Int J Mol Sci. 2024 Oct 17;25(20):11170. doi: 10.3390/ijms252011170.

Real-world assessment of caregiver preference and compliance to treatment with twice-weekly versus daily rivastigmine patches in Alzheimer's disease

García-Alberca JM, De La Guía P, Gris E, Mendoza S, López De La Rica M, López-Trigo JA, López-Mongil R, García-López T, López-García R, Rodríguez Del Rey T, Gay-Puente J, García-Castro J, Casales F, Morato X, Boada M, González-Velasco G, Marín-Carmona JM, Páez NI, León M, Carrillejo R, Rius F, Barbancho MÁ, Lara JP, Blanco-Reina E.

J Alzheimers Dis. 2024 Dec;102(3):866-876. doi: 10.1177/13872877241292018. Epub 2024 Nov 5.

Future Therapeutic Strategies for Alzheimer's Disease: Focus on Behavioral and Psychological Symptoms

Kwon KJ, Kim HY, Han SH, Shin CY.

Int J Mol Sci. 2024 Oct 22;25(21):11338. doi: 10.3390/ijms252111338.

Demographics, comorbidities, and comedications in newly diagnosed patients with Alzheimer's disease and related dementias: Findings from United States Medicare claims data

Schroeder KM, Afonso AS, Wang H, Grace S, Phipps A, Sims JR.

J Alzheimers Dis. 2024 Nov;102(2):506-519. doi: 10.3233/JAD-231488. Epub 2024 Nov 13.

[New Alzheimer's treatments - a need for national preparations and coordination]

Granberg T, Börjesson Hanson A, Fällmar D, Basun H, Wahlund LO.

Lakartidningen. 2024 Nov 20;121:24067.

Recent Progress in Nanomedicine for the Diagnosis and Treatment of Alzheimer's Diseases

Yang H, Tan H, Wen H, Xin P, Liu Y, Deng Z, Xu Y, Gao F, Zhang L, Ye Z, Zhang Z, Chen Y, Wang Y, Sun J, Lam JWY, Zhao Z, Kwok RTK, Qiu Z, Tang BZ.

ACS Nano. 2024 Dec 17;18(50):33792-33826. doi: 10.1021/acsnano.4c11966. Epub 2024 Dec 3.

Anti-amyloid treatments in Alzheimer's disease: elegance, evidence and ethics

Daly T, Olluri A, Kurkinen M.

Adv Clin Exp Med. 2024 Dec;33(12):1303-1309. doi: 10.17219/acem/198674.

Intracerebral hemorrhage following mild ARIA-H in an APOE ε2 carrier receiving lecanemab

Ji S, Rosenbloom M.

Alzheimers Res Ther. 2024 Dec 19;16(1):265. doi: 10.1186/s13195-024-01640-3.

Therapeutic implications of necroptosis activation in Alzheimer´s disease

Carrazana E, Salvadores N.

Alzheimers Res Ther. 2024 Dec 26;16(1):275. doi: 10.1186/s13195-024-01649-8.

EGb761 Trials for Mild-to-Moderate Dementia-What Have We Learned in the Past 18 years?

Necula BR, Necula RD, Petric PS, Ifteni PI, Irimie M, Dima L.

Am J Ther. 2024 Nov-Dec 01;31(6):e645-e651. doi: 10.1097/MJT.0000000000001849.

Addressing Healthy Aging: Time to Stop a Tsunami of Rising Alzheimer's Disease

Zong NC, Zhang Y, Huang Y, Cai H.

Aging Dis. 2024 Nov 28;16(6):3229-3232. doi: 10.14336/AD.2024.1476.

[Radiological Identification and Evaluation of Amyloid-Related Imaging Abnormalities in Alzheimer's Disease]

Yang X, Li W, Yang X, Chen Q, Li H, Lyu S, Hu N.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2024 Nov 20;55(6):1364-1370. doi: 10.12182/20241160201.

APOE4 is a Risk Factor and Potential Therapeutic Target for Alzheimer's Disease

Ayyubova G.

CNS Neurol Disord Drug Targets. 2024;23(3):342-352. doi: 10.2174/1871527322666230303114425.

Long-term antipsychotic use, orthostatic hypotension and falls in older adults with Alzheimer's disease

Dyer AH, Murphy C, Dolphin H, Morrison L, Briggs R, Lawlor B, Kennelly SP; NILVAD Study Group.

Eur Geriatr Med. 2024 Apr;15(2):527-537. doi: 10.1007/s41999-023-00910-x. Epub 2024 Jan 2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias